← Back to Search
Evidence Against A Role For SV40 Infection In Human Mesotheliomas And High Risk Of False-positive PCR Results Owing To Presence Of SV40 Sequences In Common Laboratory Plasmids
F. Lopez-Rios, P. Illei, V. Rusch, M. Ladanyi
Published 2004 · Medicine, Biology
Download PDFAnalyze on Scholarcy
BACKGROUND PCR-based evidence of infection by simian virus 40 (SV40) has been reported in varying proportions of pleural mesotheliomas and other tumours, but data are conflicting and reproducibility limited. During a study of SV40 in relation to homozygous deletion of CDKN2A in mesotheliomas, we became concerned by inconsistent results and therefore used several independent techniques to investigate SV40 in these tumours. METHODS High-quality DNA and RNA were extracted from 71 frozen mesothelioma samples. DNA PCR was done with four sets of primers for the SV40 T-antigen gene. RNA transcripts were examined by RT-PCR. FINDINGS The first two primer sets for DNA PCR gave positive results in proportions similar to those reported in positive studies (56-62%) but there were unusual reproducibility difficulties. These primers were in a region of the T-antigen gene (nucleotides 4100-4713) that is present in many common laboratory plasmids. In assays with PCR primers not included within that region, only four cases (6%) showed products but these were too faint to suggest clonal infection. Further PCR assays confirmed that the SV40 sequences in the tumour samples had a deletion found only in plasmids, not in native functional SV40. Review of previous studies showed a similar pattern of discrepancies between SV40 T-antigen DNA PCR results obtained with primers within and beyond the region 4100-4713. All 71 mesotheliomas were negative for T-antigen transcripts by RT-PCR, and lacked T-antigen-positive tumour cells by immunohistochemistry. INTERPRETATION Our data based on three independent experimental approaches do not support a significant role for SV40 in human mesotheliomas. The risk of false-positive results due to contamination by common laboratory plasmids containing SV40 sequences has been underestimated. Studies of SV40 based on PCR methods require careful primer design to reduce this risk. RELEVANCE TO PRACTICE This paper presents several lines of evidence against the proposed link between SV40 infection and human mesotheliomas. Studies reporting a high prevalence of SV40 DNA in human tumours have been based on molecular assays prone to false-positive results. Because SV40 appears unlikely to have a major role, if any, in human mesotheliomas, clinicians should continue to consider asbestos exposure as the most likely and most thoroughly established aetiological factor in individuals with this cancer.
This paper references
SV40 large T-antigen and human pleural mesothelioma
K. Dhaene (1999)
Lack of serological evidence for an association between simian virus 40 and lymphoma
S. de Sanjosé (2003)
A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens.
H. D. Strickler (2001)
Re: Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines.
R. Vilchez (2003)
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma
P. Cacciotti (2001)
A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas.
J. Testa (1998)
Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.
E. Engels (2003)
Detection of SV40 sequences in human mesothelioma.
D. Griffiths (1998)
The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
A. Luca (1997)
Simian virus 40 sequences and expression of the viral large T antigen oncoprotein in human pleomorphic adenomas of parotid glands.
M. Martinelli (2002)
A broad spectrum PCR method for the detection of polyomaviruses and avoidance of contamination by cloning vectors.
C. Völter (1998)
The gene for the cyclin‐dependent‐kinase‐4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma
J. Prins (1998)
Simian virus 40 (SV40): a possible human polyomavirus. Natcher Auditorium, NIH, Bethesda, Maryland, USA, January 27 and 28, 1997.
F. Brown (1998)
Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
W. Knowles (2003)
Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey.
S. Emri (2000)
Simian virus 40-like DNA sequences in human pleural mesothelioma.
M. Carbone (1994)
The vector homology problem in diagnostic nucleic acid hybridization of clinical specimens.
R. Ambinder (1986)
Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes.
A. Vivaldi (2003)
Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53.
H. Salewski (1999)
Simian virus 40, poliovaccines and human tumors: a review of recent developments
M. Carbone (1997)
Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors.
D. Rollison (2003)
Simian virus 40 infectionin lymphoproliferative disorders
D. Capello (2003)
Conventional epidemiology and the link between SV40 and human cancers.
R. Vilchez (2003)
Absence of simian virus 40 in human brain tumors from northern India
E. Engels (2002)
SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals.
F. Martini (1996)
Absence of SV40 large T-antigen expression in human mesothelioma cell lines.
Y. Pilatte (2000)
The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols
F. Mayall (2003)
Spurious DNA blot hybridization resulting from bacterial contamination of primary tissue preparations.
M. D. Howell (1987)
Erratum: Lack of serological evidence for an association between simian virus 40 and lymphoma (International Journal of Cancer (2003) 104 (522-524))
S. Sanjosé (2003)
Detection of plasmid contamination in PCR samples.
M. Nerenberg (1991)
SV40 and cell cycle perturbations in malignant mesothelioma.
J. Testa (2001)
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines.
H. Strickler (2003)
SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors
Y. Tzeng (1998)
Absence of SV‐40 large T antigen (Tag) in malignant mesothelioma effusions: An immunocytochemical study
A. Simsir (2001)
Absence of SV40 in Austrian Tumors Correlates with Low Incidence of Mesotheliomas
A. Leithner (2002)
Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines.
G. Gordon (2002)
SV40 and human tumours: myth, association or causality?
A. Gazdar (2002)
Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences.
H. Pass (1998)
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
C. Gorman (1982)
Does SV40 infection contribute to the development of human cancers?
K. Shah (2000)
SV40‐like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non‐malignant pulmonary diseases
F. Galateau-Sallé (1998)
Association between simian virus 40 DNA and lymphoma in the United kingdom.
J. Mackenzie (2003)
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood.
D. Bergsagel (1992)
Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors
F. Martini (2002)
SV40 and human brain tumors
M. Carbone (2003)
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates.
H. Strickler (1998)
Association between simian virus 40 and non-Hodgkin lymphoma
R. Vilchez (2002)
Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
P. Lin (1999)
The large T antigen of simian virus 40 binds and inactivates p53 but not p73.
M. Dobbelstein (1998)
Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors.
J. Lednicky (1995)
Codeletion of p15 and p16 in primary malignant mesothelioma.
S. Xio (1995)
Association of SV40 with human tumours.
B. Jasani (2001)
The INK4a/ARF network in tumour suppression
C. Sherr (2001)
Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium)
R. Hübner (2004)
Response: More About: Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease.
J. Butel (2000)
Association of SV40 with human tumors
G. Klein (2002)
Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells.
I. Waheed (1999)
Simian virus 40 and pleural mesothelioma in humans.
H. Strickler (1996)
SV40 in human cancers--an endless tale?
H. Hausen (2003)
Detection of Polyomavirus Simian Virus 40 Tumor Antigen DNA in AIDS‐Related Systemic Non‐Hodgkin Lymphoma
R. Vilchez (2002)
Simian virus 40 (SV40)–like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40‐contaminated polio vaccines
A. Hirvonen (1999)
Simian virus 40 and human pleural mesothelioma
C. Mulatero (1999)
Transforming functions of Simian Virus 40
M. T. Sáenz-Robles (2001)
Expression of a bacterial gene in mammalian cells.
R. Mulligan (1980)
Genomic rearrangements in a mouse cell line containing integrated SV40 DNA
R. Sager (1981)
Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences.
J. Kim (2002)
Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.
P. Illei (2003)
Simian virus 40 infection in lymphoproliferative disorders
D. Capello (2003)
Sv40 in human cancers—An endless tale?
Harald zur Hausen Editor-in-Chief (2003)
This paper is referenced by
Implications of P16/CDKN2A deletion in pleural mesotheliomas.
M. Ladanyi (2005)
Mesothelioma due to environmental exposure to erionite in Turkey
O. Dikensoy (2008)
Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality
S. Selitsky (2018)
Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance.
Amanda L. Cleaver (2014)
Epidemiology of peritoneal mesothelioma: a review.
P. Boffetta (2007)
Malignant pleural mesothelioma: an epidemiological perspective.
Benjamin M. Robinson (2012)
Comments on the introduction of the paper "Overview of the biochemical and genetic processes in malignant mesothelioma"
Algranti Eduardo (2014)
Management of malignant pleural mesothelioma.
S. West (2006)
Virus expression detection reveals RNA-sequencing contamination in TCGA
S. Selitsky (2020)
Molecular Identification of Simian Virus 40 Infection in Healthy Italian Subjects by Birth Cohort
V. Paracchini (2005)
Carcinogenicity of malaria and of some polyomaviruses.
Véronique Bouvard (2012)
No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden.
Annika Lundstig (2007)
Detection of polyomaviruses and herpesviruses in human adrenal tumors
L. Barzon (2008)
Comments on the introduction of the paper "Overview of the biochemical and genetic processes in malignant mesothelioma" Comentários sobre a introdução do artigo "Panorama dos processos bioquímicos e genéticos presentes no mesotelioma maligno"
Eduardo Algranti (2014)
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma
B. Davidson (2011)
No Detection of Simian Virus 40 in Malignant Mesothelioma in Korea
M. Eom (2013)
Is there a role for SV40 in human cancer?
Danielle L Poulin (2006)
Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
H. Yang (2008)
Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy.
J. Vargas (2008)
Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution.
C. Pancaldi (2009)
Evidence against a role for SV40 in human mesothelioma.
J. Manfredi (2005)
Pleura and Peritoneum
M. Sheaff (2007)
The carboxyl-terminal domain of large T antigen rescues SV40 host range activity in trans independent of acetylation.
Danielle L Poulin (2006)
Molecular biology of malignant mesothelioma: a review.
E. Pisick (2005)
Diseases of the Pleura
H. Popper (2017)
Human retinoblastoma is not caused by known pRb‐inactivating human DNA tumor viruses
M. Gillison (2007)
Simian virus 40 in humans
F. Martini (2006)
A conditional mouse model for malignant mesothelioma.
J. Jongsma (2008)
Simian virus 40 and mesothelioma in Great Britain.
M. Price (2007)
World Journal of Transplantation
C. Costa (2013)
1. Comment évaluer une exposition à l’amiante et identifier une population à risque?
J. Pairon (2006)
JC virus large T‐antigen and IGF‐I signaling system merge to affect DNA repair and genomic integrity
K. Reiss (2006)See more